Related Experiment Video
Updated: Feb 14, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Phosphocreatine in Cardiac Surgery Patients: A Meta-Analysis of Randomized Controlled Trials
Fang Mingxing1, Giovanni Landoni2, Alberto Zangrillo2
1Department of Intensive Care, The Third Hospital, Hebei Medical University, Shijiazhuang, Hebei Province, P.R. China.
Insights
Phosphocreatine (PCr) may improve cardiac surgery outcomes by reducing arrhythmias and the need for inotropic support. While PCr showed benefits in recovery, further large-scale studies are needed for clinical significance validation.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biochemistry
Background:
- Phosphocreatine (PCr) has shown potential in mitigating ischemia/reperfusion injury in the heart.
- Cardiac surgery patients are at risk for myocardial damage and arrhythmias.
Purpose of the Study:
- To evaluate the efficacy of phosphocreatine (PCr) in improving cardiac performance and outcomes in patients undergoing cardiac surgery compared to standard treatment.
- To assess PCr's impact on intraoperative support, arrhythmias, and postoperative cardiac function.
Main Methods:
- A meta-analysis of 26 randomized controlled trials involving 1,948 adult and pediatric patients undergoing cardiac surgery.
- Searched multiple databases including PubMed/Medline, Embase, Scopus, and Cochrane Library up to March 1, 2017.
- Analyzed data using random and fixed-effects models to calculate odds ratios and mean differences.
Main Results:
- PCr use was linked to significantly lower rates of intraoperative inotropic support (27% vs. 44%) and major arrhythmias (16% vs. 28%).
- Patients receiving PCr demonstrated a higher spontaneous recovery of cardiac rhythm post-aortic declamping (50% vs. 34%).
- PCr administration showed a trend towards decreased myocardial damage and improved left ventricular ejection fraction, though these effects were not clinically significant.
Conclusions:
- Phosphocreatine (PCr) administration in cardiac surgery is associated with reduced intraoperative inotropic support and major arrhythmias.
- PCr may enhance spontaneous cardiac rhythm recovery after aortic declamping.
- Larger multicenter trials are necessary to confirm these findings and establish clinical significance.
Objective:
There is experimental evidence that phosphocreatine (PCr) can decrease ischemia/reperfusion injury of the heart. The authors investigated if PCr would improve heart performance as compared with standard treatment in cardiac surgery.
Design:
Meta-analysis of randomized controlled trials.
Setting:
Hospitals.
Participants:
Adult and pediatric patients undergoing cardiac surgery.
Interventions:
The ability of PCr to improve cardiac outcomes as compared with standard treatment was investigated.
Measurements And Main Results:
PubMed/Medline, Embase, Scopus, Cochrane Library, China National Knowledge Infrastructure, WANGFANG DATA, and VIP Paper Check System were searched to March 1 2017. The authors included 26 randomized controlled trials comprising 1,948 patients. Random and fixed-effects models were used to estimate odds ratio (OR) and mean difference (MD) with 95% confidence interval (CI). PCr use was associated with reduced rates of intraoperative inotropic support (27% v 44%; OR 0.47, 95% CI 0.35-0.61; p < 0.001), major arrhythmias (16% v 28%; OR 0.44, 95% CI 0.27-0.69; p < 0.001), as well as increased spontaneous recovery of the cardiac rhythm immediately after aortic declamping (50% v 34%; OR 2.45, 95% CI 1.82-3.30; p < 0.001) as compared with standard treatment. The use of PCr decreased myocardial damage and augmented left ventricular ejection fraction in the postoperative period; however, MD for these outcomes were small and do not seem to be clinically significant.
Conclusions:
In randomized trials, PCr administration was associated with reduced rates of intraoperative inotropic support and major arrhythmias, and increased spontaneous recovery of the cardiac rhythm after aortic declamping. Large multicenter evidence is needed to validate these findings.
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
Trial and Error and Algorithm
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Directing Effect of Substituents: meta-Directing Groups
Random Error

